Parkinson’s Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility

被引:5
|
作者
Yan Y. [1 ]
Shimoga D. [1 ]
Sharma A. [1 ]
机构
[1] Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Georgia, Augusta University, 1120 15th Street, AD 2226, Augusta, 30912, GA
关键词
Diabetes; Gastrointestinal; GLP-1 receptor agonists; Gut-brain axis; Nonmotor symptoms; Parkinson’s Disease;
D O I
10.1007/s11894-023-00868-7
中图分类号
学科分类号
摘要
Purpose of Review: Parkinson’s disease and diabetes affect an increasing proportion of the aging global population. Both conditions extensively affect gastrointestinal (GI) motility with similar and differing clinical symptoms. Nonetheless, GI symptoms in Parkinson’s disease and diabetes pose significant morbidity and impairment of quality of life. Their pathophysiology is poorly understood, and therefore, effective treatment options are lacking. Recent Findings: Parkinson’s disease patients have oropharyngeal dysphagia and constipation. They also have mild or absent upper GI symptoms associated with delayed gastric emptying, which is prevalent in 70% of patients. Delayed gastric emptying in Parkinson’s disease leads to erratic medication absorption and fluctuating motor symptoms. Half of diabetics have upper GI symptoms, which correlate to gastric emptying and changes in brain activity of the insular cortex. The majority of diabetics also have constipation. Diabetics have an increased risk for developing Parkinson’s disease and anti-diabetic medications are associated with risk reduction of developing Parkinson’s disease. Hyperglycemia is associated with advanced glycated end products formation and acceleration of α-synuclein aggregation. GLP-1 receptor agonists have also demonstrated efficacy in improving motor symptoms and cognition in Parkinson’s disease patients with diabetes. Summary: Parkinson’s disease and diabetes are pan-enteric disorders with significant GI symptoms and impairment of gut motility. Both conditions have synergistic pathophysiologies that propagate neurodegenerative changes. Treatment options for GI symptoms in diabetic and Parkinson’s disease patients are lacking. Anti-diabetic treatment improves motor symptoms in Parkinson’s disease, however, its effect on GI symptoms is unclear. © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码:106 / 113
页数:7
相关论文
共 50 条
  • [31] Tau in the Pathophysiology of Parkinson's Disease
    Pan, Lina
    Meng, Lanxia
    He, Mingyang
    Zhang, Zhentao
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2021, 71 (11) : 2179 - 2191
  • [32] Pathophysiology of bradykinesia in Parkinson's disease
    Berardelli, A
    Rothwell, JC
    Thompson, PD
    Hallet, M
    BRAIN, 2001, 124 : 2131 - 2146
  • [33] Type 2 Diabetes Mellitus and Alzheimer's Disease: Bridging the Pathophysiology and Management
    Alam, Fahmida
    Islam, Md. Asiful
    Sasongko, Teguh Haryo
    Gan, Siew Hua
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (28) : 4430 - 4442
  • [34] Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease
    Ong, Marissa
    Foo, Heidi
    Chander, Russell Jude
    Wen, Ming-Ching
    Au, Wing Lok
    Sitoh, Yih Yian
    Tan, Louis
    Kandiah, Nagaendran
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 377 : 122 - 126
  • [35] The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease
    Cheong, Julia L. Y.
    de Pablo-Fernandez, Eduardo
    Foltynie, Thomas
    Noyce, Alastair J.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (03) : 775 - 789
  • [36] Parkinson's disease and diabetes mellitus:common mechanisms and treatment repurposing
    Carmen M.Labandeira
    Arturo Fraga-Bau
    David Arias Ron
    Elena Alvarez-Rodriguez
    Pablo Vicente-Alba
    Javier Lago-Garma
    Ana I.Rodriguez-Perez
    Neural Regeneration Research, 2022, 17 (08) : 1652 - 1658
  • [37] Parkinson's disease and diabetes mellitus: common mechanisms and treatment repurposing
    Labandeira, Carmen M.
    Fraga-Bau, Arturo
    Ron, David Arias
    Alvarez-Rodriguez, Elena
    Vicente-Alba, Pablo
    Lago-Garma, Javier
    Rodriguez-Perez, Ana I.
    NEURAL REGENERATION RESEARCH, 2022, 17 (08) : 1652 - 1658
  • [38] Ocular motility in Parkinson's disease
    Repka, MX
    Claro, MC
    Loupe, DN
    Reich, SG
    JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 1996, 33 (03) : 144 - 147
  • [39] Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease
    Tripathy, D.
    Chakraborty, J.
    Mohanakumar, K. P.
    FREE RADICAL RESEARCH, 2015, 49 (09) : 1129 - 1139
  • [40] Gallbladder motility in obesity, diabetes mellitus and coeliac disease
    Fraquelli, M
    Pagliarulo, M
    Colucci, A
    Paggi, S
    Conte, D
    DIGESTIVE AND LIVER DISEASE, 2003, 35 : S12 - S16